Literature DB >> 18307732

Cardiovascular and metabolic effects of obesity.

Margaret J Morris1.   

Abstract

1. Obesity is an important risk factor for hypertension and its incidence is increasing around the world. 2. The mechanisms underlying obesity-related hypertension include sympathetic activation, altered vascular responses, hormonal changes, enhanced inflammatory markers and structural changes. 3. This review summarizes recent evidence of the underlying impact of obesity on blood pressure. A number of candidate mechanisms include increased sympathetic activity, activation of the renin-angiotensin system, altered vasoconstrictor or dilator responses and the attendant systemic inflammatory state. 4. While adult lifestyle factors undoubtedly contribute to the incidence of obesity and its attendant hypertension, evidence suggests that the programming of obesity may occur following over-nutrition during development. A growing body of evidence links maternal obesity, offspring obesity and hypertension. 5. Finally, epigenetic modification of genes relevant to hypertension may contribute to the development of hypertension following a suboptimal intrauterine environment. To date the cardiovascular effects of early nutritional changes have been largely investigated following maternal under-nutrition or protein restriction; further work is necessary to determine the impact of maternal obesity.

Entities:  

Mesh:

Year:  2008        PMID: 18307732     DOI: 10.1111/j.1440-1681.2008.04912.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  9 in total

1.  BK channel β1-subunit deficiency exacerbates vascular fibrosis and remodelling but does not promote hypertension in high-fat fed obesity in mice.

Authors:  Hui Xu; Hannah Garver; Roxanne Fernandes; Jeremiah T Phelps; Jack J Harkema; James J Galligan; Gregory D Fink
Journal:  J Hypertens       Date:  2015-08       Impact factor: 4.844

2.  Self-weighing frequency is associated with weight gain prevention over 2 years among working adults.

Authors:  Jeffrey J VanWormer; Jennifer A Linde; Lisa J Harnack; Steven D Stovitz; Robert W Jeffery
Journal:  Int J Behav Med       Date:  2012-09

3.  Sympathetic overdrive in obesity involves purinergic hyperactivity in the resistance vasculature.

Authors:  Rebecca E Haddock; Caryl E Hill
Journal:  J Physiol       Date:  2011-05-16       Impact factor: 5.182

4.  Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults.

Authors:  James Tsai; Earl S Ford; Guixiang Zhao; Chaoyang Li; Kurt J Greenlund; Janet B Croft
Journal:  J Behav Med       Date:  2011-05-28

5.  Genetic and dietary effects on dendrites in the rat hypothalamic ventromedial nucleus.

Authors:  Denise R Labelle; Julia M Cox; Ambrose A Dunn-Meynell; Barry E Levin; Loretta M Flanagan-Cato
Journal:  Physiol Behav       Date:  2009-08-19

6.  AMP-activated Protein Kinase (AMPK): Does This Master Regulator of Cellular Energy State Distinguish Insulin Sensitive from Insulin Resistant Obesity?

Authors:  X Julia Xu; Rudy J Valentine; Neil B Ruderman
Journal:  Curr Obes Rep       Date:  2014-06-01

7.  Birth Weight and Maternal Body Size as Determinants of Blood Pressure at Age 17: Results from the Jerusalem Perinatal Study Cohort.

Authors:  Uri P Dior; Gilad Karavani; Michael Bursztyn; Ora Paltiel; Ronit Calderon-Margalit; Yechiel Friedlander; Iaroslav Youssim; Orly Manor; Hagit Hochner
Journal:  Matern Child Health J       Date:  2020-11-28

8.  Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?

Authors:  Wen-Chi Wu; Wei-Jei Lee; Tzong-His Lee; Shu-Chun Chen; Chih-Yen Chen
Journal:  World J Diabetes       Date:  2020-06-15

9.  Novel indolic AMPK modulators induce vasodilatation through activation of the AMPK-eNOS-NO pathway.

Authors:  Marta Sanz-Gómez; Elnaz Aledavood; Marina Beroiz-Salaverri; Laura Lagartera; Elena Vega-Martín; Marta Gil-Ortega; Jose Cumella; Concepción Pérez; Francisco Javier Luque; Carolina Estarellas; María S Fernández-Alfonso; Ana Castro
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.